$OPGN FDA clearance for Unyvero was obtained already in December.
December 20, 2019, 23:30 CET -- Curetis N.V. (the "Company" and,
together with its subsidiaries, "Curetis"),
a developer of next-level molecular diagnostic solutions,
today announced that the Company has received 510(k) clearance by
the U.S. Food and Drug Administration (FDA) to market its Unyvero
LRT Lower Respiratory Tract Application Cartridge